The unusual m6A modification caused by differentially expressed METTL13 or METTL14 plays a critical role in the malignant progression of various cancers, such as bladder cancer, gastric cancer, and hepatocellular carcinoma (HCC) [17–19]. This evidence concerns the gene METTL13 and hepatocellular carcinoma.